The prospect for cytokine based therapeutic strategies in rheumatoid arthritis.

This publication has 25 references indexed in Scilit:

• Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome
  JAMA, 1994
• Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment
  Clinical and Experimental Immunology, 1994
• A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha
  European Journal of Immunology, 1994
• Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
  Arthritis & Rheumatism, 1993
• An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.
  The Journal of Experimental Medicine, 1993
• Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis
  The Lancet, 1993
• Production of interleukin-1-receptor antagonist during experimental endotoxaemia
  The Lancet, 1991
• Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist
  Nature, 1990
• CORRELATION OF PLASMA INTERLEUKIN 1 LEVELS WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
  Published by Elsevier ,1988
• Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).
  Journal of Clinical Investigation, 1986